Hillstream BioPharma is a biotechnology business based in the US. Hillstream BioPharma shares (HILS) are listed on the NASDAQ and all prices are listed in US Dollars. Hillstream BioPharma employs 1 staff and has a market cap (total outstanding shares value) of 0.00.
Offer ends 4/1/25. Customer must fund their Active invest account with at least $50 within 30 days of opening the account. Probability of customer receiving $2,000 is 0.028%. See full terms and conditions at https://www.sofi.com/greenintwoterms/.
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – HILS.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy Hillstream BioPharma stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Hillstream BioPharma stock price (NASDAQ: HILS)
Use our graph to track the performance of HILS stocks over time.
Is it a good time to buy Hillstream BioPharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Hillstream BioPharma financials
Gross profit TTM
$0
Return on assets TTM
-77.97%
Return on equity TTM
-147.31%
Profit margin
0%
Book value
$0.18
Market Capitalization
$4.2 million
TTM: trailing 12 months
Hillstream BioPharma share dividends
We're not expecting Hillstream BioPharma to pay a dividend over the next 12 months.
Hillstream BioPharma's shares were
split on a 1:25 basis on 20 November 2023
. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Hillstream BioPharma shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Hillstream BioPharma shares which in turn could have impacted Hillstream BioPharma's share price.
Hillstream BioPharma overview
Hillstream BioPharma, Inc. , a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-3215, an anti-HER2 monoclonal antibody candidate; and HSB-1940, a Quatrabody that is a proprietary IO biologic in development targeting PD-1. The company was incorporated in 2017 and is based in Bridgewater, New Jersey. .
Frequently asked questions
null What percentage of Hillstream BioPharma is owned by insiders or institutions? Currently 38.909% of Hillstream BioPharma shares are held by insiders and 0.89% by institutions.How many people work for Hillstream BioPharma? Latest data suggests 1 work at Hillstream BioPharma.When does the fiscal year end for Hillstream BioPharma? Hillstream BioPharma's fiscal year ends in December.Where is Hillstream BioPharma based? Hillstream BioPharma's address is: 1200 Route 22 East, Bridgewater, NJ, United States, 08807What is Hillstream BioPharma's ISIN number? Hillstream BioPharma's international securities identification number is: US4327051011What is Hillstream BioPharma's CUSIP number? Hillstream BioPharma's Committee on Uniform Securities Identification Procedures number is: 432705101
A deep dive into the highlights and limitations of Robinhood.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
